Clonazepam description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Clonazepam

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CLONAZEPAM DESCRIPTION



Clonazepam

CLINICAL PHARMACOLOGY


PHARMACODYNAMICS



PHARMACOKINETICS




Clinical Trials:








INDICATIONS & USAGE




CLlNICAL PHARMACOLOGY: Clinical Trials

DOSAGE AND ADMINISTRATION

CLONAZEPAM CONTRAINDICATIONS



WARNINGS

PRECAUTIONS: Drug InteractionsInformation for Patients










Pregnancy Risks:









DRUG ABUSE AND DEPENDENCE

PRECAUTIONS

General






INFORMATION FOR PATIENTS





WARNINGS: Pregnancy RisksPRECAUTIONS: Pregnancy




DRUG INTERACTIONS







CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY






PREGNANCY

WARNINGS: Pregnancy Risks


LABOR & DELIVERY

WARNINGS: Pregnancy Risks

NURSING MOTHERS



PEDIATRIC USE

INDICATIONS AND USAGEDOSAGE AND ADMINISTRATION


GERIATRIC USE





CLONAZEPAM ADVERSE REACTIONS














































DRUG ABUSE AND DEPENDENCE

Controlled Substance Class

DOSAGE AND ADMINISTRATION
CLINICAL PHARMACOLOGY: Clinical Trials

OVERDOSAGE







DOSAGE & ADMINISTRATION






PRECAUTIONS: Geriatric Use




PRECAUTIONS: Geriatric Use

HOW SUPPLIED






STORAGE AND HANDLING










SPL MEDGUIDE




































































































PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Clonazepam

Clonazepam

Clonazepam

Clonazepam TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-319(NDC:0228-3003)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CLONAZEPAM CLONAZEPAM 0.5 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
D&C RED NO. 30

Product Characteristics

Color Size Imprint Code Shape
pink 8 mm R;33 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-319-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074869 2011-06-22


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.